RhumbLine Advisers’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $426K | Sell |
|
|||||
|
2025
Q2 | $558K | Buy |
|
|||||
|
2025
Q1 | $540K | Buy |
|
|||||
|
2024
Q4 | $831K | Buy |
|
|||||
|
2024
Q3 | $1.05M | Buy |
|
|||||
|
2024
Q2 | $948K | Buy |
|
|||||
|
2024
Q1 | $796K | Buy |
|
|||||
|
2023
Q4 | $466K | Buy |
|
|||||
|
2023
Q3 | $409K | Sell |
|
|||||
|
2023
Q2 | $497K | Sell |
|
|||||
|
2023
Q1 | $523K | Buy |
|
|||||
|
2022
Q4 | $493K | Buy |
|
|||||
|
2022
Q3 | $587K | Buy |
|
|||||
|
2022
Q2 | $553K | Buy |
|
|||||
|
2022
Q1 | $336K | Buy |
|
|||||
|
2021
Q4 | $472K | Sell |
|
|||||
|
2021
Q3 | $700K | Buy |
|
|||||
|
2021
Q2 | $387K | Buy |
|
|||||
|
2021
Q1 | $483K | Buy |
|